# ATT Trading Framework — ATE Development Journal

**Owner:** Paul Austin

**Repository:** `ATT-Trading-Framework`

**Primary implementation:** Pine Script v6

**Research orientation:** daily-first diagnostics, with governed weekly companion studies

## Purpose

This journal records the actual ATE diagnostic lineage. It distinguishes implementation, verification, empirical validation, and Product Owner approval. It does not treat a compiling indicator or a passing verifier as proof of diagnostic usefulness.

## Historical foundation

### 2026-06-30 — Milestone 1A / v0.1.0

- Repository and development workflow established.
- Initial EMA 50/200 framework created.
- Paul Austin confirmed the initial Pine script compiled in TradingView.

This milestone is retained as project history; it is no longer the current milestone.

## Diagnostic release lineage

### ATE v2.1 — VolatilityEngine diagnostic baseline

- VolatilityEngine `1.0.0-draft` implemented for dashboard and Research Mode output only.
- Paul Austin confirmed the v2.1 Pine release compiled in TradingView.
- RDR-002 daily and RDR-002W weekly both classified the engine **Weakly Supported** and recommended **Keep Diagnostic**.
- ConfidenceEngine, RiskEngine, and DecisionEngine consumption was not approved by those studies.

### ATE v2.2 — RiskEngine diagnostic baseline

- Immutable release: `pine/releases/ATE_v2.2.pine`.
- RiskEngine `1.0.0-draft` added as diagnostic dashboard and Research Mode output.
- The release preserves the existing trend score, StructureEngine, MomentumEngine, ConfidenceEngine, VolatilityEngine, visuals, and ten indicator-event alerts.
- RiskEngine does not change confidence, create alerts, or publish `riskApproved`; it has no trade approval or rejection authority.
- Paul Austin confirmed the immutable v2.2 release compiled cleanly in TradingView after the preserved confidence-bear alert was restored.
- Canonical release verification covered source integrity, engine boundaries, output variables, dashboard/research fields, and preserved alert behaviour.
- RDR-003 daily classified RiskEngine **Weakly Supported** and recommended **Keep Diagnostic**.
- RDR-003W weekly classified it **Supported** for controlled weekly research use while retaining **Keep Diagnostic** and all downstream prohibitions.
- Pine-versus-research-mirror parity remains a distinct evidence gate before stronger implementation-equivalence or downstream claims.

### Development-only TrendEngine research cycle

- TrendEngine `0.2.0-spec-impl` was specified and added only to `pine/development/ATE_Current.pine`.
- It is additive and parallel to the immutable v2.2 `trendScore` / `marketState`; it does not replace or feed them.
- Deterministic Python-mirror fixtures and canonical verifier checks cover its research contract and boundaries.
- Empirical usefulness remains deferred to a future RDR-010 re-attempt.
- No TradingView compile claim is recorded for this development-only implementation.
- It is not promoted to `pine/releases/ATE_v2.2.pine` and has no ConfidenceEngine, RiskEngine, DecisionEngine, alert, or action coupling.

## Current milestone — documentation and evidence alignment

Completed:

- [x] Immutable ATE v2.2 diagnostic baseline retained.
- [x] Existing as-built Structure, Momentum, Confidence, and Dashboard behaviour documented.
- [x] Volatility and Risk diagnostic RDR evidence recorded without overstating it.
- [x] Development-only TrendEngine separated from release/compile claims.
- [x] DecisionEngine explicitly deferred.

Next governed research steps:

- [ ] Complete any required Pine-versus-research-mirror parity study.
- [ ] Re-attempt empirical TrendEngine validation when authorised.
- [ ] Investigate weak/negative RiskEngine and VolatilityEngine findings before proposing any reclassification.
- [ ] Keep implemented, verified, validated, and approved status separate in every release and research record.

## Scope boundary

ATE remains a diagnostic and research framework. The current milestone excludes DecisionEngine/action logic, trade approval, entries, exits, orders, broker connectivity, paper/live execution, position sizing, stop placement, and trade management. Any future scope change requires separate evidence, specification, governance review, and explicit approval.
